Microvascular Function

Pipeline Programs↗

Active Trials↗

Companies Involved↗

Microvascular Function is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

60/100

Attrition Rate

22/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

clinical trials

Completed3 · 33%

Terminated2 · 22%

Not yet recruiting1 · 11%

Unknown status1 · 11%

Active, not recruiting1 · 11%

Enrolling by invitation1 · 11%

Clinical Trials

Trial Activity

9 trials

Estrogen and Microvascular Function

Active, not recruiting·MMedical College of Wisconsin·N/A·NCT06043310·45 enrolled

Palmitic Acid and Human Microvascular Function

Not yet recruiting·MMedical College of Wisconsin·Phase 2·NCT06683534·40 enrolled

The Effect of Adiposity on Muscle and Microvascular Function in HFpEF

Enrolling by invitation·UUniversity of Texas Southwestern Medical Center·N/A·NCT06930495·100 enrolled

The Microvascular Function of GLP-1 and Its Analogues

Completed·—·N/A·NCT01677104·63 enrolled

Effects of Continuous Dexmedetomidine Infusion on Systemic Microvascular Function in Laparoscopic Cholecystecthomy

Completed·National Institute of Cardiology, Laranjeiras, Brazil·N/A·NCT04946396·64 enrolled

Microvascular Function Assessment in Healthy Subjects

Completed·UUniversity Hospital, Angers·N/A·NCT01572961·16 enrolled

Aldosterone Antagonism and Microvascular Function

Terminated·MMaastricht University Medical Center·Phase 4·NCT01887119·25 enrolled

Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular Function

Terminated·LLudwig-Maximilians - University of Munich·Phase 3·NCT03082014·101 enrolled

A Randomized Trial of Intracoronary Reopro to Improve Coronary Microvascular Function

Unknown status·UUniversity of Melbourne·N/A·NCT02105870·40 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)